Alyeska Investment Group
SPRB

Alyeska Investment Group’s Spruce Biosciences SPRB Stock Holding History

Alyeska Investment Group’s Portfolio SPRB Stock Details SPRB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.38M Hold
51,671
– – 0.01% 517
2025
Q4 		$4.5M Buy
+51,671
New +$5.54M 0.01% 470
2024
Q1 		– Sell
-5,333
Closed -$1.17M – 640
2023
Q4 		$1.17M Sell
5,333
-8,000
-60% -$924K 0.01% 402
2023
Q3 		$2.26M Hold
13,333
– – 0.02% 383
2023
Q2 		$2.15M Hold
13,333
– – 0.02% 405
2023
Q1 		$2.21M Buy
+13,333
New +$2.48M 0.02% 349
2021
Q3 		– Sell
-259
Closed -$218K – 816
2021
Q2 		$218K Buy
+259
New +$276K ﹤0.01% 683

Other funds holding SPRB

IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.29% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return
QOP
Quinn Opportunity Partners Charlottesville, Virginia $2.16B AUM 28.56% 1-Year Est. Return
ECM
ExodusPoint Capital Management New York $15.5B AUM 38.81% 1-Year Est. Return

Alyeska Investment Group's SPRB Position: Q1 2026 in Review

Alyeska Investment Group held its Spruce Biosciences (SPRB) position steady in Q1 2026 at 51,671 shares worth $3.38M. The position accounts for 0.01% of the portfolio, ranked #517.

Alyeska Investment Group first reported a position in SPRB in Q2 2021 and has held it in 7 quarters since. The position peaked at $4.5M in Q4 2025. 32 funds tracked by Wall St. Rank hold SPRB as of Q1 2026.

  • Alyeska Investment Group held 51,671 shares of Spruce Biosciences worth $3.38M as of Q1 2026.
  • Alyeska Investment Group left its Spruce Biosciences share count unchanged in Q1 2026.
  • Spruce Biosciences made up 0.01% of Alyeska Investment Group's portfolio in Q1 2026, its #517 holding.
  • Alyeska Investment Group first reported a position in Spruce Biosciences in Q2 2021 and has held it in 7 quarters since.
  • Alyeska Investment Group's Spruce Biosciences position peaked at $4.5M in Q4 2025.
  • 32 funds tracked by Wall St. Rank held Spruce Biosciences as of Q1 2026.

Based on Alyeska Investment Group's 13F filing for Q1 2026, filed 15 May 2026.